Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABX209: Abraxane, Carboplatin, and Gemcitabine in Advanced Urothelial Cancer
NCT00995488Phase 2Terminated
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Oct 2009
- Primary completion
- Nov 2013
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in urothelial carcinoma (UC), sponsored by University of Michigan Rogel Cancer Center. Started Oct 2009; status: terminated.
02
Drugs
nab-paclitaxel
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00995488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00995488.